A group of physicians has raised concerns about the safety of Covishield vaccine following AstraZeneca's admission of rare side effects. They urge the Indian government to review vaccine science, implement monitoring mechanisms, and compensate victims. AstraZeneca has initiated a global withdrawal of its vaccine, citing updated options available. Serum Institute of India ceased production in 2021.